Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04752215
Title A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
Valkyrie Clinical Trials Los Angeles California 90067 United States Details
University of California Irvine Orange California 92868 United States Details
HealthONE Denver Colorado 80218 United States Details
Orlando Health Cancer Institute Orlando Florida 32806 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Norton Healthcare - Norton Cancer Institute - Louisville Louisville Kentucky 40202 United States Details
New York University Langone Medical Center New York New York 10016 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
SCRI Oncology Partners Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75230 United States Details
Baylor University Medical Center Dallas Texas 75246 United States Details
Princess Margaret Cancer Centre Toronto M5G 1Z5 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field